Guerisoli Brent
SEC CIK 1838360 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PNTG | Pennant Group, Inc. | Pres | 99.5K | — | $748.9K | 16 | 2022-07-25 | 2026-08-06 |
Most active insiders at PNTG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Guerisoli Brent | CEO | — | $582.7K |
| 2 | Steik Jason Paul | Chief Clinical Off | — | $53.7K |
| 3 | Cheney Kirk Sterling | EVP, GC, Corp Secy | — | $53.7K |
| 4 | Walbom Lynette | CFO | — | — |
| 5 | Morris Gregory K Sr. | Dir | — | — |
| 6 | Gochnour John J | COO | — | — |
| 7 | Snapper Suzanne D. | Dir | — | — |
| 8 | Nackel John G. | Dir | — | — |
| 9 | Christensen Christopher R. | Dir | — | — |
| 10 | Lamb Scott E | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 15:49 | 2026-08-06 | PNTG | Pennant Group, Inc. | Guerisoli Brent | CEO | S - Sale | $38.52 | -4,285 | 99.5K | -4% | -$165.1K | |
| DT | 2026-07-14 12:16 | 2026-07-10 | PNTG | Pennant Group, Inc. | Guerisoli Brent | CEO | M - OptEx | $4.54 | +6,248 | 107.0K | +6% | +$28.4K |
| DT | 2026-07-14 12:16 | 2026-07-10 | PNTG | Pennant Group, Inc. | Guerisoli Brent | CEO | S - Sale+OE | $41.56 | -3,159 | 103.8K | -3% | -$131.3K |
| DT | 2026-07-09 11:32 | 2026-07-07 | PNTG | Pennant Group, Inc. | Guerisoli Brent | CEO | M - OptEx | $4.54 | +6,249 | 103.9K | +6% | +$28.4K |
| DT | 2026-07-09 11:32 | 2026-07-07 | PNTG | Pennant Group, Inc. | Guerisoli Brent | CEO | S - Sale+OE | $40.51 | -3,165 | 100.7K | -3% | -$128.2K |
| DMT | 2026-05-27 15:41 | 2026-05-22 | PNTG | Pennant Group, Inc. | Guerisoli Brent | CEO | M - OptEx | $3.84 | +8,926 | 99.9K | +10% | +$34.3K |
| DMT | 2026-05-27 15:41 | 2026-05-22 | PNTG | Pennant Group, Inc. | Guerisoli Brent | CEO | S - Sale+OE | $35.08 | -4,508 | 97.7K | -4% | -$158.1K |
| DA | 2026-04-17 19:02 | 2026-03-03 | PNTG | Pennant Group, Inc. | Guerisoli Brent | CEO | A - Grant | $0.00 | +11.3K | 93.2K | +14% | $0 |
| D | 2026-03-12 | 2026-03-03 | PNTG | Pennant Group, Inc. | Guerisoli Brent | CEO | A - Grant | $0.00 | +20.1K | 102.0K | +24% | $0 |
| 2025-07-31 | 2025-07-28 | PNTG | Pennant Group, Inc. | Guerisoli Brent | CEO | S - Sale | $23.34 | -3,995 | 82.0K | -5% | -$93.2K | |
| 2025-03-14 | 2025-03-03 | PNTG | Pennant Group, Inc. | Guerisoli Brent | CEO | A - Grant | $0.00 | +4,734 | 86.0K | +6% | $0 | |
| DM | 2024-08-30 | 2024-08-27 | PNTG | Pennant Group, Inc. | Guerisoli Brent | Pres | S - Sale+OE | $34.74 | -1,418 | 81.2K | -2% | -$49.3K |
| DM | 2024-08-30 | 2024-08-27 | PNTG | Pennant Group, Inc. | Guerisoli Brent | Pres | M - OptEx | $7.42 | +2,515 | 82.7K | +3% | +$18.7K |
| D | 2024-02-27 | 2024-02-23 | PNTG | Pennant Group, Inc. | Guerisoli Brent | Pres | M - OptEx | $5.31 | +2,514 | 81.5K | +3% | +$13.3K |
| D | 2024-02-27 | 2024-02-23 | PNTG | Pennant Group, Inc. | Guerisoli Brent | Pres | S - Sale+OE | $17.11 | -1,385 | 80.1K | -2% | -$23.7K |
| 2022-07-27 | 2022-07-25 | PNTG | Pennant Group, Inc. | Guerisoli Brent | Pres | A - Grant | $0.00 | +45.0K | 79.0K | +132% | $0 |
Purchase Sale Sale after option exercise All abbreviations